3623 results for «2085»
3623 results
PCI calcified lesion - Session with LIVE case
06 Oct 2022 – From AICT-AsiaPCR 2022
Watch this LIVE case preceded by a discussion regarding the PCI of a calcified lesion on a 75-year-old male with hypertension and hyperlipidemia who presented with Class III angina. Non-invasive evaluation showed significant LAD and RCA disease, normal LVEF and no significant valvular disease...
Ultra-low contrast PCI - Session with LIVE case
06 Oct 2022 – From AICT-AsiaPCR 2022
Watch this LIVE case followed by a discussion regarding a 75-year-old female with hypertension, hyperlipidemia, diabetes and stage 3 CKD, presenting with class III angina. The lab investigations revealed a diffuse triple vessel disease...
Strategies for successful medical writing
06 Oct 2022 – From AICT-AsiaPCR 2022
What a pleasure to be able to read and re-read one of your own articles once it has been published! Follow this session to get tips and tricks on how to get published and produce quality writing, and to learn how to use all media, including...
Lifetime management of patients with aortic stenosis
06 Oct 2022 – From AICT-AsiaPCR 2022
In this AICT-AsiaPCR 2022 session, review a ViV case to consider coronary occlusion and CT analysis, and examine a TAVI case to discuss failed TAVI bioprosthesis, so as to develop strategies for patients with AS and long-life expectancy.
Duration of DAPT in high bleeding risk and FFR guided PCI vs. CABG for TVD: a guide to interpreting non-inferiority trials
07 Oct 2022 – From AICT-AsiaPCR 2022
Take advantage of this AICT-AsiaPCR 2022 session to learn in detail about the FAME 3 and MASTER-DAPT trials and how to use their results in daily practice, and to better understand what is behind the term "non-inferiority" and when and how to choose a non-inferiority margin.
Rotational atherectomy for the treatment of calcified coronary lesion - Session with LIVE case
07 Oct 2022 – From AICT-AsiaPCR 2022
Let's see how this 80-year-old female patient with hypertension, hyperlipidaemia, diabetes mellitus, chronic kidney disease, history of ischaemic heart disease (2018) and NSTEMI (August 2022), currently asymptomatic but mainly homebound, was treated LIVE, and learn more about the treatment of calcified coronary lesion.
DCB in variable day-to-day clinical scenarios
07 Oct 2022 – From AICT-AsiaPCR 2022
In this AICT AsiaPCR 2022 session 4 cases will be discussed that will enable you to learn more about drug-coated balloons and the variable indications for their use in daily practice, or techniques for using them in different lesion settings.
Treatment of calcified lesions
07 Oct 2022 – From AICT-AsiaPCR 2022
Consider a 66-year-old man, hypertensive and diabetic for 10 years, with history of recurrent substernal chest pain and exertional dyspnea, who presented with easy fatigability and shortness of breath, or a 72-year-old man on dialysis who presented with STEMI and severe calcified stenosis of LAD/DI bifurcation,...
AICT-AsiaPCR 2022 Opening Ceremony
06 Oct 2022 – From AICT-AsiaPCR 2022
After two years without being able to meet, the joy of opening this 2022 session of the AICT-AsiaPCR Congress is palpable in this video broadcasting the opening ceremony. After a quick retrospective of the previous editions, the presenters unveil the objectives of this 2022 version and...
Beyond the guidelines of STEMI management: challenges in Southeast Asia
06 Oct 2022 – From AICT-AsiaPCR 2022
In this session, observe several challenging STEMI cases, such as a 48-year-old non-smoking Thai man with gout admitted for chest pain, or a 68-year-old woman with a history of HT, DM2, and PAD who presented with an anterior lateral STEMI and was indicated for PPCI, and...
Rapid-fire abstracts: session 1
27 Nov 2022 – From PCR London Valves 2022
Watch this PCR LV 2022 session to get clinical outcomes after TAVR in obese and non-obese patients with small aortic annuli, to find out how non-calcific aortic valve tissue quantified from coronary CT angiography can predict one-year mortality post-TAVI, and even more!
PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI
21 Nov 2021 – From PCR London Valves
Real-world outcomes for tricuspid edge-to-edge repair, predictors of heart failure hospitalisation and its impact on clinical outcomes, one-year outcomes after TMVI... View part of the Late-Breaking Trials presented during PCR London Valves 2021.
Transcatheter mitral valve replacement: patient selection and hemodynamic stability
22 Nov 2021 – From PCR London Valves
Watch this session broadcast at PCR London Valves 2021 to find out more about TMVR as a novel treatment option for patients with mitral disease, to learn how to identify the right candidate for TMVR, and to understand how to best medically manage patients peri-procedurally.
Obtaining commissural alignment in TAVI
23 Nov 2021 – From PCR London Valves 2021
Watch this session from PCR London Valves 2021 about the importance of commissural alignment in TAVI to know how to achieve commissural alignment with different TAVI systems, and to discover a step-by-step demonstration of patient-specific commissural alignment with the ACURATE neo2 THV system.
Lifetime management of patients with severe aortic stenosis
22 Nov 2021 – From PCR London Valves
Don't miss this PCR London Valves 2021 session if you wish to discuss the importance of lifetime management in patients with severe aortic stenosis, to learn about the latest CoreLab adjudicated outcomes from the Early neo2 registry, and to understand how valve design, implant technique, embolic...
Predictability at release means better MR outcomes; PASCAL platform significance in a matched analysis
21 Nov 2021 – From PCR London Valves 2021
Join Peter Lüdike and Philipp Lurz to learn more about about the latest study regarding the predictability of mitral regurgitation reduction using the PASCAL device.
Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform
23 Nov 2021 – From PCR London Valves
Explore the clinical impact of the Edwards portfolio of transcatheter devices for mitral regurgitation treatment in this PCR London Valves 2021 session that you shouldn't miss if you want to attend case-based discussions that will analyze key PASCAL features to treat mitral regurgitation and to participate...
EAPCI: patient initiatives around the world
22 Nov 2021 – From PCR London Valves 2021
In this session, you can find out more about the EAPCI Valve for Life initiative and what progress has been made in selected countries, as well as other collaborative initiatives across the world.
From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options
21 Nov 2021 – From PCR London Valves 2021
Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned. Bernard Prendergast, Philipp Lurz, Fabien Praz and Maurizio Taramasso discuss the challenges and needs regarding mitral and tricuspid valve disease treatment. They also consider what is needed to...
From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options - Part 1 - Best long-term outcomes start with the first procedure
21 Nov 2021 – From PCR London Valves
In this session from PCR London Valve 2021 dedicated to TAVI, mitral, and tricuspid, let's examine the issues related to the lifetime patient journey faced by many patients, starting with an analysis of severe aortic stenosis: how to identify the most important factors when considering the...
